Anti-RV-A VP7 Polyclonal Antibody from ProteoGenix; catalogue ARO-A22452; research use only.
Know who made it. See the evidence. Buy through one marketplace.
Anti-RV-A VP7 Polyclonal Antibody: A Powerful Tool for Studying Rotavirus Infection
The Anti-RV-A VP7 Polyclonal Antibody is a highly specific and sensitive tool for studying rotavirus infection. This antibody targets the VP7 protein of rotavirus, a major causative agent of severe diarrhea in infants and young children. With its high affinity and specificity, this antibody is ideal for various research applications, including immunofluorescence, Western blotting, and ELISA.
The VP7 protein is a major structural component of rotavirus, responsible for its outer capsid. It plays a crucial role in viral entry and pathogenesis by interacting with host cells and facilitating viral replication. The Anti-RV-A VP7 Polyclonal Antibody specifically binds to the VP7 protein, allowing for the detection and analysis of rotavirus in infected samples.
1. Immunofluorescence: The Anti-RV-A VP7 Polyclonal Antibody can be used in immunofluorescence assays to visualize the presence and localization of rotavirus in infected cells. Its high sensitivity and specificity make it a valuable tool for studying the dynamics of rotavirus infection.
2. Western Blotting: This antibody can also be used in Western blotting to detect the presence of rotavirus in various samples. Its ability to specifically target the VP7 protein allows for the accurate identification of rotavirus in complex samples.
3. ELISA: The Anti-RV-A VP7 Polyclonal Antibody can be used in enzyme-linked immunosorbent assays (ELISA) to quantify the amount of rotavirus in a sample. Its high affinity and sensitivity make it an ideal tool for detecting even low levels of rotavirus.
1. Understanding Rotavirus Pathogenesis: By using the Anti-RV-A VP7 Polyclonal Antibody in immunofluorescence assays, researchers can study the interaction between the VP7 protein and host cells, providing valuable insights into the mechanisms of rotavirus infection and pathogenesis.
2. Vaccine Development: The VP7 protein is a major target for rotavirus vaccine development. The Anti-RV-A VP7 Polyclonal Antibody can be used to screen potential vaccine candidates and evaluate their efficacy in inducing an immune response against rotavirus.
3. Clinical Diagnosis: The Anti-RV-A VP7 Polyclonal Antibody can be used in ELISA to detect and quantify rotavirus in clinical samples, providing a rapid and accurate diagnostic tool for rotavirus infection.
Conclusion:
The Anti-RV-A VP7 Polyclonal Antibody is a highly specific and sensitive tool for studying rotavirus infection. Its ability to specifically target the VP7 protein makes it an ideal choice for various research applications, including immunofluorescence, Western blotting, and ELISA. By using this antibody, researchers can gain a better understanding of rotavirus pathogenesis, aid in vaccine development, and improve clinical diagnosis of rotavirus infection.
ProteoGenix catalogue number ARO-A22452. For research use only.
Target: Outer capsid glycoprotein VP7; Clonality: Polyclonal Antibody; Applications: ELISA, IHC.
Available configurations: 50ug, 100ug, 1mg.
Fully tested in-house by ABMIUM, or supported by an advanced validation report from a partner reviewed by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Target | WB | IHC-P | IHC-Fr | IF/ICC | Flow Cyt | IP | ChIP | ELISA | IHC |
|---|---|---|---|---|---|---|---|---|---|
| Outer capsid glycoprotein VP7 |
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
